Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Comment by Don2018on Dec 20, 2019 9:25am
123 Views
Post# 30476148

RE:Not one, but two definitive agreements around the corner

RE:Not one, but two definitive agreements around the corner
wexworth wrote: Lot's packed into the update today.

The way that I see it, there are three very real elements that are highly probable within the first quarter 2020. When they come to light, we will see the impacts we are looking for:

1) Tinyi and Sirona move from term sheet to definitive agreement, which includes confirmation the CMO is ready to go.

2) Early new year, a double whammy corporation deal on TFC-039

3) Confirmation that product starts shipping out the door on Roden

These seem obvious, but all three should have a profound impact on the forward balance sheet.


You may as well quit trying to make predictions for SBM, as you have been wrong 100% of the time.

Just let them do their job, and quit making promises they can't keep.
Bullboard Posts